23 related articles for article (PubMed ID: 15664349)
1. Insights into accelerated liposomal release of topotecan in plasma monitored by a non-invasive fluorescence spectroscopic method.
Fugit KD; Jyoti A; Upreti M; Anderson BD
J Control Release; 2015 Jan; 197():10-9. PubMed ID: 25456833
[TBL] [Abstract][Full Text] [Related]
2. Quantification of Unencapsulated Drug in Target Tissues Demonstrates Pharmacological Properties and Therapeutic Effects of Liposomal Topotecan (FF-10850).
Kimura T; Okada K; Morohashi Y; Kato Y; Mori M; Kato H; Matsumoto T; Shimoyama S
Pharm Res; 2024 Apr; 41(4):795-806. PubMed ID: 38536615
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence detection of the anticancer drug topotecan in plasma and whole blood by two-photon excitation.
Burke TG; Malak H; Gryczynski I; Mi Z; Lakowicz JR
Anal Biochem; 1996 Nov; 242(2):266-70. PubMed ID: 8937572
[TBL] [Abstract][Full Text] [Related]
4. Effect of the combined binding of topotecan and catechin/protocatechuic acid to a pH-sensitive DNA tetrahedron on release and cytotoxicity: Spectroscopic and calorimetric studies.
Wang L; Liu J; Wang X; Li X; Zhang X; Yuan L; Wu Y; Liu M
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Jun; 314():124179. PubMed ID: 38522375
[TBL] [Abstract][Full Text] [Related]
5. PK/TD modeling for prediction of the effects of 8C2, an anti-topotecan mAb, on topotecan-induced toxicity in mice.
Shah DK; Balthasar JP
Int J Pharm; 2014 Apr; 465(1-2):228-38. PubMed ID: 24508555
[TBL] [Abstract][Full Text] [Related]
6. Predicting the effects of 8C2, a monoclonal anti-topotecan antibody, on plasma and tissue disposition of topotecan.
Shah DK; Balthasar JP
J Pharmacokinet Pharmacodyn; 2014 Feb; 41(1):55-69. PubMed ID: 24368689
[TBL] [Abstract][Full Text] [Related]
7. Physiologically based pharmacokinetic model for topotecan in mice.
Shah DK; Balthasar JP
J Pharmacokinet Pharmacodyn; 2011 Feb; 38(1):121-42. PubMed ID: 21104004
[TBL] [Abstract][Full Text] [Related]
8. Use of an anti-vascular endothelial growth factor antibody in a pharmacokinetic strategy to increase the efficacy of intraperitoneal chemotherapy.
Shah DK; Shin BS; Veith J; Tóth K; Bernacki RJ; Balthasar JP
J Pharmacol Exp Ther; 2009 May; 329(2):580-91. PubMed ID: 19233938
[TBL] [Abstract][Full Text] [Related]
9. Mathematical modeling of topotecan pharmacokinetics and toxicodynamics in mice.
Chen J; Lu Q; Balthasar JP
J Pharmacokinet Pharmacodyn; 2007 Dec; 34(6):829-47. PubMed ID: 17885736
[TBL] [Abstract][Full Text] [Related]
10. Validation and pharmacokinetic application of a method for determination of doxazosin in human plasma by high-performance liquid chromatography.
Sripalakit P; Nermhom P; Saraphanchotiwitthaya A
Biomed Chromatogr; 2006 Aug; 20(8):729-35. PubMed ID: 16235201
[TBL] [Abstract][Full Text] [Related]
11. Sensitive high performance liquid chromatographic assay for assessment of doxorubicin pharmacokinetics in mouse plasma and tissues.
Urva SR; Shin BS; Yang VC; Balthasar JP
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Mar; 877(8-9):837-41. PubMed ID: 19246257
[TBL] [Abstract][Full Text] [Related]
12. High-performance liquid chromatographic assay for the determination of total and free topotecan in the presence and absence of anti-topotecan antibodies in mouse plasma.
Chen J; Balthasar JP
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):183-92. PubMed ID: 15664349
[TBL] [Abstract][Full Text] [Related]
13. Determination of topotecan in human and mouse plasma and in mouse tissue homogenates by reversed-phase high-performance liquid chromatography.
de Vries NA; Ouwehand M; Buckle T; Beijnen JH; van Tellingen O
Biomed Chromatogr; 2007 Nov; 21(11):1191-200. PubMed ID: 17582233
[TBL] [Abstract][Full Text] [Related]
14. Simple and sensitive high performance liquid chromatographic method for the simultaneous quantitation of the lactone and carboxylate forms of topotecan in human plasma.
Vali AM; Shafaghi B; Dadashzadeh S
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(2):205-12. PubMed ID: 15734160
[TBL] [Abstract][Full Text] [Related]
15. Determination of plasma topotecan and its metabolite N-desmethyl topotecan as both lactone and total form by reversed-phase liquid chromatography with fluorescence detection.
Bai F; Kirstein MN; Hanna SK; Iacono LC; Johnston B; Stewart CF
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Feb; 784(2):225-32. PubMed ID: 12505770
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
